Elmind Capital »

Immunocore Holdings Plc- shares owned by Elmind Capital

Quarter-by-quarter ownership of Immunocore Holdings Plc- (IMCR) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Immunocore Holdings Plc-

Tip: Access up to 7 years of quarterly data

All positions including Immunocore Holdings Plc- held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunocore Holdings Plc- by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 58k 30.15

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Cytomx Therapeutics (CTMX)
Kalvista Pharmaceuticals (KALV)
Cg Oncology (CGON)
Vera Therapeutics Cl A (VERA)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Tyra Biosciences (TYRA)
Beam Therapeutics (BEAM)
Miragen Therapeutics (VRDN)
BioCryst Pharmaceuticals (BCRX)
United Therapeutics Corporation (UTHR)
Cullinan Oncology (CGEM)

View all positions for Elmind Capital

Top funds holding Immunocore Holdings Plc-

T. Rowe Price Investment Management
Rtw Investments
Wellington Management Company
FMR
PRIMECAP Management Company
Bellevue Group
Vestal Point Capital
Tang Capital Management
Deep Track Capital
Logos Global Management
BVF
Millennium Management
Armistice Capital
Point72 Asset Management
Fiera Capital Corporation

View all funds holding Immunocore Holdings Plc-